J Cannon Clifton

Title: J Cannon Clifton: Innovator in Ketamine Infusion Therapy

Introduction

J Cannon Clifton is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of medical treatment, particularly in the area of mental health and pain management. His innovative approach to therapy has the potential to change the way patients experience treatment for depression and pain.

Latest Patents

J Cannon Clifton holds a patent for a method of treatment involving ketamine infusion. This method includes the administration of a first preparation comprising an antiemetic agent, preferably ondansetron, followed by a second preparation of a synergistic combination of ketamine and a benzodiazepine, preferably lorazepam. This treatment is administered via a continuous intravenous infusion. The methods proposed may better alleviate symptoms of depression and pain, potentially reducing the need for other medications. He has 1 patent to his name.

Career Highlights

Clifton is associated with Eleusis Therapeutics US, Inc., where he continues to develop and refine his innovative treatment methods. His work is focused on improving patient outcomes and enhancing the efficacy of existing therapies.

Collaborations

Some of his notable coworkers include Mark Alan Moran and John Bryan Clifton, who contribute to the collaborative efforts at Eleusis Therapeutics US, Inc. Their combined expertise fosters an environment of innovation and advancement in therapeutic methods.

Conclusion

J Cannon Clifton's work in ketamine infusion therapy represents a significant advancement in the treatment of depression and pain. His innovative methods have the potential to improve patient care and outcomes in the medical field.